|« Previous month||Next month »|
31-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Sirona, Hospira, and Biogen Idec.
31-Jan-2012 - DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.
31-Jan-2012 - Ingredient maker Dishman Pharmaceuticals has confirmed that it may offload its Chinese API (active pharmaceutical ingredients) factory.
31-Jan-2012 - Cephalon is recalling a single lot of leukaemia treatment Treanda after glass fragments were found in a vial.
31-Jan-2012 - The FDA has hit Novartis with another 483 after finding seven repeat observations and a backlog of 1,360 overdue consumer complaints.
30-Jan-2012 - BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound at less than cost to...
30-Jan-2012 - Patheon will focus its upcoming growth efforts on solubility enhancing tech after receiving an influx of requests from clients.
30-Jan-2012 - The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.
30-Jan-2012 - Zogenix is collaborating with Battelle to out-license its needle-free drug delivery technology, DosePro.
27-Jan-2012 - Danone and Mead Johnson may make a joint bid for the €8bn infant nutrition-dominated Pfizer nutrition business that is up for sale, according to press reports.
26-Jan-2012 - in-PharmaTechnologist presents a round-up of issues within the pharmaceutical manufacturing industry, including Novartis’ plans to restart Nebraska ops and problems for Roche at it’s South Carolina facility.
26-Jan-2012 - The US has filed a “groundbreaking” injunction against Ranbaxy to force the generic giant to make “fundamental changes” at its plants.
26-Jan-2012 - Simplification of French tax laws would incentivise Pharmas to manufacture drugs in the country according to a government advisory body.
26-Jan-2012 - Europe is considering forcing API manufacturers to verify the source of starting materials as part of GMP revisions.
25-Jan-2012 - in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
25-Jan-2012 - Ibuprofen API maker Albemarle says favourable volumes and pricing helped drive gains made by fine chemicals unit in Q4.
25-Jan-2012 - Vivalis nearly doubled revenues from its vaccine production platform in 2011 and has inked a third mAb discovery programme with Sanofi.
25-Jan-2012 - Ashland is investing in production assets and raising prices as it looks to get the most from its $3.2bn acquisition.
24-Jan-2012 - in-PharmaTechnololist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Prosonix, GENO, and BioCryst.
24-Jan-2012 - Granules India says Big Pharma demand for highly efficient manufacturing in era of patent loss helped it gain market share in Q3 fiscal 2012.
24-Jan-2012 - The FDA has followed the EMA in approving the Framingham, MA plant that Genzyme hopes will cut production bottlenecks.
24-Jan-2012 - PolyPid plans to begin clinical development of its novel lipid-polymer fusion-based drug delivery technology with new through a new financing round.
24-Jan-2012 - Sartorius Stedim Biotech (SSB) says its partnership with Refine Technology will help meet demand for greater connectivity between retention devices and bioreactors and save Pharmas time and money
23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.
23-Jan-2012 - Alnylam is cutting its headcount by one-third to lower operating costs as it attempts to bring an RNAi product to market.
23-Jan-2012 - The EMA has revised guidelines on active substance master files (ASMF) to stop multiple EU nations assessing the same documents.
23-Jan-2012 - Poor aseptic technique at compounding pharmacies is the most likely cause of Avastin-related vision loss, researchers claim.
19-Jan-2012 - SGS’ new analytical lab in Mumbai, India will open later this week just six months after the analytical services firm began its construction .
19-Jan-2012 - Sartorius Stedum Biotech (SSB) and G-Con Manufacturing claim their biomanufacturing technology partnership will change the ‘fundamentals’ of process design.
19-Jan-2012 - Drug delivery firm NovaDel has warned it lacks the cash to continue beyond this month and may file for bankruptcy protection.
19-Jan-2012 - The FDA has published a QbD approach to modified release tablet development to help generic companies meet its 2013 deadline.
18-Jan-2012 - A new study has found a way to use air as a barrier for controlled drug release.
18-Jan-2012 - Takeda has announced it will cut 2,800 jobs by 2015 as part of its integration of Nycomed.
18-Jan-2012 - Enzymicals and Herbrand PharmaChemicals have partnered to incorporate biocatalytic processes into fine chemical manufacturing.
18-Jan-2012 - Sigma-Aldrich is prioritising HPAPIs as it seeks to grow its custom pharma business in the face of low-cost competition.
17-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest career moves within the pharmaceutical industry, including news from Algeta, Pall and Octapharma.
17-Jan-2012 - Pharma giant GlaxoSmithKline (GSK) has moved its offices in charge of the Middle East and North African (MENA) market to Istanbul, Turkey.
17-Jan-2012 - Excipient makers could save up to 200 man hours with a new industry-driven, third-party audit certification scheme set to launch next week.
17-Jan-2012 - PIC/S has strengthened promotion of global GDP harmonisation and confidentiality in a revision to its documentation.
17-Jan-2012 - The US FDA plans to study foreign regulators’ GMP inspection reports with a view to using them to support its enforcement efforts.
16-Jan-2012 - A new discovery platform for RNA delivery vehicles could mean 20 per cent more efficiency for guiding nanoparticles into cancer cells, say researchers.
16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.
16-Jan-2012 - Swiss drug major Novartis has announced plans to cut US jobs and predicts a challenging couple of years for its pharma division.
16-Jan-2012 - The Chinese government is encouraging development of new vaccine production processes in a bid to achieve self-reliance.
12-Jan-2012 - Clinigen and PCAS have inked a long term supply pact for the production of the API for Foscavir.
12-Jan-2012 - US scientists say a new N-heterocycles synthesis method could open door to the production of novel antibiotics, cancer and pain drugs.
12-Jan-2012 - NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.
12-Jan-2012 - The lack of transparency when Puerto Rico imposed a new tax in 2010 may deter drugmakers from expanding on the island, a report found.
11-Jan-2012 - Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
11-Jan-2012 - Ashland says it will ramp up production of the tablet disintegrant and dissolution aid polyvinylpyrrolidone (PVPP) to meet growing drug industry demand.
11-Jan-2012 - Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.
11-Jan-2012 - Sanofi announced it will cut $170m of its operational costs this year as it plans to ramp-up acquisitions spending to $2.6bn.
11-Jan-2012 - in-PharmaTechnologist presents its weekly round-up of the latest new faces at pharmas and biotechs, including news from Dicerna, Auxilium and Essentialis.
11-Jan-2012 - Hospira will uncover more issues as it gets to the root cause of its quality troubles but the situation is “very fixable”, its CEO said.
10-Jan-2012 - Drug delivery tech firm SkyePharma has started reviewing operations at its facility in Muttenz, Switzerland in a move that could results in significant job cuts.
10-Jan-2012 - Delivery tech firm MonoSol Rx and nanoparticle excipient developer Midatech have set up a new diabetes-focused joint venture (JV).
10-Jan-2012 - Zhongxi Sunve has bought a stake in a Chinese oncology API manufacturer and has further takeovers in the pipeline.
10-Jan-2012 - Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.
10-Jan-2012 - The value of counterfeit pharmaceuticals seized at US borders jumped 200 per cent in 2011 as enforcement actions took effect.
09-Jan-2012 - Further analysis is needed to assess the risk posed by low level pharmaceutical contamination of water supplies says the winner of Recipharm’s 2011 environmental award.
09-Jan-2012 - Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.
09-Jan-2012 - Novartis expects to take a $120m charge to improve a US manufacturing plant and recall drugs after the FDA sent it a 483.
09-Jan-2012 - Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.
09-Jan-2012 - The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.
05-Jan-2012 - R&D software firm Accelrys says it will speed up the pharma QA/QC process and reduce the compliance risk ten-fold through its $35m takeover of VelQuest.
05-Jan-2012 - The US Food and Drug Administration (FDA) will soon start asking drugmakers to play a greater role in guideline development . Before that process begins in-Pharmatechnologist.com takes a look at the...
05-Jan-2012 - Gulf Pharmaceutical Industries is set to become the first insulin maker in the Middle East with its new $136m plant in Ras Al Khaimah, UAE.
05-Jan-2012 - Phase I data shows Alnylam a “very potent” RNAi delivery platform that can be the foundation of its future, the company’s CEO said.
05-Jan-2012 - India is sending a delegation to Chile, Peru, Columbia and Venezuela to boost pharma exports to Latin America.
04-Jan-2012 - GSK CEO Andrew Witty has been knighted in the Queen's New Year Honours list in recognition of his services to the UK economy and pharmaceutical industry.
04-Jan-2012 - Supply chain security group Rx-360 has warned that guar gum – a thickening agent that is widely used in the drug industry – is in short supply.
04-Jan-2012 - The FDA should encourage industry to submit draft guidance to speed regulatory development, an agency working group found.
04-Jan-2012 - The Indian pharmaceutical industry faces “intense competition” from China as it tries to grow exports to $25bn, the country's commerce minister said.
03-Jan-2012 - New Zealand researchers have developed a delivery method in which drugs are transferred to their targets in a resealable 'metallosupramolecular cage'.
03-Jan-2012 - The European Commission (EC) has set out its plans for ‘equivalence assessments’ for manufacturers in countries seeking to export APIs to Europe.
03-Jan-2012 - OPKO Health has bought Israel-based API (active pharmaceutical ingredient) maker FineTech Pharmaceutical.
03-Jan-2012 - in-PharmaTechnologist presents its first weekly round-up of the new appointments in the industry of 2012, including news from Teva, Forma Therapeutics and Celgene.
02-Jan-2012 - BASF’s new multi-functional plastic film will raise the bar for purity levels in synthetic excipients, says the firm.
02-Jan-2012 - India has released draft guidance on stability data needed to support approval of Phase I to III clinical trials.
02-Jan-2012 - A new nanostructured polymer can release anti-cancer drugs once it hits body temperature, according to research.
|« Previous month||Next month »|